Purdue Research Foundation;Chong Kun Dang Pharmaceutical Corp.
发明人:
Gwangheum Yoon,Bong Kwan Soh,Andrew David Otte,Kinam Park
申请号：
US16653707
公开号：
US20200113835A1
申请日:
2019.10.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure relates to naltrexone sustained release microparticle delivery systems for the treatment of diseases ameliorated by naltrexone. The injectable microparticle delivery system includes naltrexone encapsulated in biodegradable microparticles administered in a pharmaceutically acceptable vehicle.
